Since its founding in 2017, ZYMVOL has established itself as a leader in computational enzyme discovery and design. The company collaborates with the R&D teams of some of the world’s largest compani...
Read moreResearchers from the Bellvitge Biomedical Research Institute (IDIBELL) and the Germans Trias i Pujol Research Institute (IGTP) have studied variations in the length of mRNAs during the progression of ...
Read moreResearchers identify predictive markers of response to immunotherapy treatment in a study involving data from over 700 patients across six different cohorts, published in Nature Communications.
Read morePersonal investigador del Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC) y el Hospital Universitario Reina Sofía (HURS), ha identificado, por primera vez, la existencia de pa...
Read moreUn grupo de investigación del Centro Andaluz de Biología del Desarrollo descubre una variante en el gen COQ4 que afecta la producción de energía celular. El estudio se centra en el caso de una pac...
Read moreEstos “minicerebros”, creados a partir de células madre que permiten simular el desarrollo de la enfermedad de Alzheimer y explorar en detalle los factores que contribuyen a su aparición y progr...
Read moreEl estudio observacional internacional de pacientes con Colangiocarcinoma (CCA) más exhaustivo realizado hasta la fecha en Latinoamérica, coordinado por personal investigador del Instituto de Invest...
Read moreUn equipo del Instituto de Neurociencias (CSIC-UMH) descubre que un factor esencial para la identidad neuronal se regula por un proceso llamado ‘splicing’
Read moreThe study, published in the Journal of Extracellular Vesicles, analyzes the metabolic profiles of brain tissue and extracellular vesicles obtained from those tissues in Alzheimer’s patients, uncover...
Read moreThe Parc Taulí Research and Innovation Institute (I3PT) has obtained a total of 2.604.000 Euros in competitive funding to develop sixteen health research and innovation projects
Read moreThe study focused on the detection of two HBV markers: Hepatitis B core-related antigen and HBV RNA. These two markers are detectable in the blood and reflect the activity of a unique viral DNA called...
Read moreIntegra Therapeutics has developed the FiCAT gene-writing platform to develop cell therapies for autoimmune and oncology diseases and gene therapies for rare diseases. The company recently announced a...
Read more